Key statistics
On Thursday, Actinogen Medical Ltd (3AC:DEU) closed at 0.017, 115.46% above the 52 week low of 0.0079 set on Sep 19, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.017 |
---|---|
High | 0.017 |
Low | 0.017 |
Bid | 0.0185 |
Offer | 0.0195 |
Previous close | 0.017 |
Average volume | 3.22k |
---|---|
Shares outstanding | 2.71bn |
Free float | 2.28bn |
P/E (TTM) | -- |
Market cap | 84.09m AUD |
EPS (TTM) | -0.0061 AUD |
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Press releases
- Actinogen announces further positive results on depression in the XanCIDD phase 2a trial
- Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial
- Positive Xanamem® biomarker trial published in the Journal of Alzheimer's Disease demonstrating potential Xanamem efficacy in patients with elevated blood pTau